Post-Transplantation Cyclophosphamide for Prevention of Graft-Versus-Host Disease after HLA-Matched Related and Unrelated Donor Peripheral Blood Stem Cell Transplantation

被引：0
|
作者：
Miekarek, Marco [1 ,2 ]
Furlong, Terry [1 ]
O'Donnell, Paul V. [1 ]
Storer, Barry E. [1 ]
McCune, Jeannine S. [1 ]
Storb, Rainer F. [2 ,3 ]
Carpenter, Paul A. [1 ]
Flowers, Mary E. D. [1 ,2 ]
Appelbaum, Frederick R. [1 ,2 ]
Martin, Paul J. [1 ,2 ]
机构：
[1] Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA
[2] Univ Washington, Dept Med, Seattle, WA USA
[3] Fred Hutchinson Canc Res Ctr, Div Clin Res, Transplantat Biol Program, 1124 Columbia St, Seattle, WA 98104 USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2016年 / 22卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S406 / S406
页数：1
相关论文
共 50 条
  • [31] Experience Using Anti-Thymocyte Globulin With Post-Transplantation Cyclophosphamide for Graft-Versus-Host Disease Prophylaxis in Peripheral Blood Haploidentical Stem Cell Transplantation
    Queralt Salas, Maria
    Atenafu, Eshetu G.
    Datt Law, Arjun
    Lam, Wilson
    Pasic, Ivan
    Chen, Carol
    Kim, Dennis
    Michelis, Fotios, V
    Gerbitz, Armin
    Howard Lipton, Jeffrey
    Mattsson, Jonas
    Kumar, Rajat
    Viswabandya, Auro
    TRANSPLANTATION AND CELLULAR THERAPY, 2021, 27 (05): : 428.e1 - 428.e9
  • [32] Results of a 2-Arm, Phase 2 Clinical Trial Using Post-Transplantation Cyclophosphamide for the Prevention of Graft-Versus-Host Disease in Haploidentical Donor and Mismatched Unrelated Donor Hematopoietic Stem Cell Transplantation
    Gaballa, Sameh
    Ge, Isabell
    El Fakih, Riad
    Brammer, Jonathan E.
    Kongtim, Piyanuch
    Tomuleasa, Ciprian
    Wang, Sa A.
    Lee, Dean
    Petropoulos, Demetrios
    Cao, Kai
    Rondon, Gabriela
    Chen, Julianne
    Hammerstrom, Aimee
    Lombardi, Lindsey
    Alatrash, Gheath
    Korbling, Martin
    Oran, Betul
    Kebriaei, Partow
    Ahmed, Sairah
    Shah, Nina
    Rezvani, Katayoun
    Marin, David
    Bashir, Qaiser
    Alousi, Amin
    Nieto, Yago
    Qazilbash, Muzaffar
    Hosing, Chitra
    Popat, Uday
    Shpall, Elizabeth J.
    Khouri, Issa
    Champlin, Richard E.
    Ciurea, Stefan O.
    CANCER, 2016, 122 (21) : 3316 - 3326
  • [33] Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation
    Przepiorka, D
    Petropoulos, D
    Mullen, CA
    Danielson, M
    Mattewada, V
    Chan, KW
    BONE MARROW TRANSPLANTATION, 1999, 23 (12) : 1291 - 1295
  • [34] Tacrolimus for prevention of graft-versus-host disease after mismatched unrelated donor cord blood transplantation
    D Przepiorka
    D Petropoulos
    CA Mullen
    M Danielson
    V Mattewada
    K-W Chan
    Bone Marrow Transplantation, 1999, 23 : 1291 - 1295
  • [35] Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma
    Nakaya, Yosuke
    Nakamae, Hirohisa
    Nishikubo, Masashi
    Kondo, Eisei
    Fukuda, Takahiro
    Hiramoto, Nobuhiro
    Mori, Yasuo
    Nagafuji, Koji
    Eto, Tetsuya
    Onishi, Yasushi
    Uchida, Naoyuki
    Ishikawa, Jun
    Matsuoka, Ken-ichi
    Yui, Shunsuke
    Takase, Ken
    Kawakita, Toshiro
    Kanda, Junya
    Ichinohe, Tatsuo
    Atsuta, Yoshiko
    Kako, Shinichi
    BONE MARROW TRANSPLANTATION, 2024, 59 (05) : 630 - 636
  • [36] Hydroxychloroquine for the prevention of acute graft-versus-host disease after unrelated donor transplantation
    Khoury, H
    Trinkaus, K
    Zhang, MJ
    Adkins, D
    Brown, R
    Vij, R
    Goodnough, LT
    Ma, MK
    McLeod, HL
    Shenoy, S
    Horowitz, M
    DiPersio, JF
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2003, 9 (11) : 714 - 721
  • [37] Peripheral blood stem cell transplantation using HLA-haploidentical donor with post-transplant cyclophosphamide versus HLA-matched sibling donor for lymphoma
    Yosuke Nakaya
    Hirohisa Nakamae
    Masashi Nishikubo
    Eisei Kondo
    Takahiro Fukuda
    Nobuhiro Hiramoto
    Yasuo Mori
    Koji Nagafuji
    Tetsuya Eto
    Yasushi Onishi
    Naoyuki Uchida
    Jun Ishikawa
    Ken-ichi Matsuoka
    Shunsuke Yui
    Ken Takase
    Toshiro Kawakita
    Junya Kanda
    Tatsuo Ichinohe
    Yoshiko Atsuta
    Shinichi Kako
    Bone Marrow Transplantation, 2024, 59 : 630 - 636
  • [38] A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
    Jamy, Omer
    Innis-Shelton, Racquel
    Bal, Susan
    Paluri, Ravi K.
    Karim, Samina
    Chewning, Joseph H.
    Salzman, Donna
    Costa, Luciano J.
    Di Stasi, Antonio
    Lamb, Lawrence S., Jr.
    Mineishi, Shin
    Saad, Ayman
    BLOOD, 2019, 134
  • [39] A Phase II Clinical Trial of Post-Transplant Cyclophosphamide for Graft Versus Host Disease Prevention Following Myeloablative Peripheral Blood Stem Cell Matched Unrelated Donor Hematopoietic Stem Cell Transplantation
    Jamy, Omer
    Innis-Shelton, Racquel
    Bal, Susan
    Salzman, Donna
    Costa, Luciano J.
    di Stasi, Antonio
    Lamb, Lawrence
    Mineishi, Shin
    Saad, Ayman
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2020, 26 (03) : S190 - S191
  • [40] Short Course of Post-Transplantation Cyclophosphamide and Bortezomib for Graft-versus-Host Disease Prevention after Allogeneic Peripheral Blood Stem Cell Transplantation Is Feasible and Yields Favorable Results: A Phase I Study
    Al-Homsi, Ahmad-Samer
    Cole, Kelli
    Bogema, Marlee
    Duffner, Ulrich
    Williams, Stephanie
    Mageed, Aly
    BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION, 2015, 21 (07) : 1315 - 1320
12345